Filtros de búsqueda

Lista de obras de

A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer ⬇️

artículo científico publicado el 1 de noviembre de 2010

A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

artículo científico publicado en 2016

A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission

artículo científico publicado en 2016

A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or Recurrent Endometrial Cancer

artículo científico publicado en 2024

A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer

scientific article published on 01 July 2018

A comparative analysis of prediction models for complete gross resection in secondary cytoreductive surgery for ovarian cancer

artículo científico publicado en 2017

A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in Phase I dose-finding studies

artículo científico publicado en 2008

A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen

artículo científico publicado en 2019

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer

artículo científico publicado en 2017

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

artículo científico publicado en 2014

A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma

artículo científico publicado en 2011

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

scientific article published on 17 January 2020

A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel

artículo científico publicado en 2017

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

artículo científico publicado en 2020

A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.

artículo científico publicado en 2007

A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors

artículo científico publicado en 2010

A reconstructed melanoma data set for evaluating differential treatment benefit according to biomarker subgroups

artículo científico publicado en 2017

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma

artículo científico publicado en 2008

Adaptive dose-finding studies: a review of model-guided phase I clinical trials

artículo científico publicado en 2014

Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort study.

artículo científico publicado en 2018

Advanced ovarian cancer and cytoreductive surgery: Independent validation of a risk-calculator for perioperative adverse events

artículo científico publicado en 2020

Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes

artículo científico publicado en 2009

An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma

artículo científico publicado en 2016

An efficient basket trial design

artículo científico publicado en 2017

BRAF Mutation is associated with early stage disease and improved outcome in patients with low‐grade serous ovarian cancer ⬇️

artículo científico publicado el 28 de agosto de 2012

BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian Cancer

scientific article published on 16 June 2020

Basket Trials in Oncology: A Trade-Off Between Complexity and Efficiency

artículo científico publicado en 2016

Bevacizumab shows activity in patients with low-grade serous ovarian and primary peritoneal cancer

artículo científico publicado en 2014

Beyond the dose-limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program

artículo científico publicado en 2016

Bridging Solutions in Dose Finding Problems

artículo científico publicado en 2014

CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy

artículo científico publicado en 2006

Characteristics and Outcome of AKT1 E17K-Mutant Breast Cancer Defined through AACR Project GENIE, a Clinicogenomic Registry

artículo científico publicado en 2020

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery

artículo científico publicado en 2020

Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies

artículo científico publicado en 2023

Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees

artículo científico publicado en 2013

Clinical Trials in the Genomic Era.

artículo científico publicado en 2017

Clinical trials: Early phase clinical trials-are dose expansion cohorts needed?

artículo científico

Coherence principles in interval-based dose finding

scientific article published on 06 November 2019

Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series

scientific article published on 10 January 2008

Consolidation strategies in ovarian cancer: observations for future clinical trials

artículo científico publicado en 2010

Continual reassessment and related designs in dose-finding studies

artículo científico publicado en 2011

Continuous improvement in primary Debulking surgery for advanced ovarian cancer: Do increased complete gross resection rates independently lead to increased progression-free and overall survival?

scientific article published on 17 August 2018

Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer

artículo científico publicado en 2020

Design considerations for dose-expansion cohorts in phase I trials

artículo científico publicado en 2013

Dimension of model parameter space and operating characteristics in adaptive dose-finding studies

artículo científico publicado en 2016

Dose expansion cohorts in Phase I trials

artículo científico publicado en 2016

Duration of second or greater complete clinical remission in ovarian cancer: exploring potential endpoints for clinical trials

scientific article published on 05 July 2007

Early phase dose finding methodology

artículo científico publicado en 2017

Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer

scientific article published on 05 July 2007

Efficacy of MEK inhibition in patients with histiocytic neoplasms

scientific article published on 13 March 2019

Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset

artículo científico publicado en 2009

Epithelial Membrane Protein-2 Is a Novel Therapeutic Target in Ovarian Cancer ⬇️

artículo científico publicado el 1 de agosto de 2010

Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a 2-cohort, phase 2 study

artículo científico publicado en 2011

Estimating the dose–toxicity curve in completed phase I studies ⬇️

artículo científico publicado el 22 de febrero de 2011

Ethical and Policy Issues for Seamless Phase I Oncology Trials

artículo científico publicado en 2019

Evaluation of an online platform for cancer patient self-reporting of chemotherapy toxicities

artículo científico publicado en 2007

Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer

artículo científico publicado en 2009

Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary Study

artículo científico publicado en 2020

Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center

artículo científico publicado en 2018

Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study

artículo científico publicado en 2023

External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer

artículo científico publicado en 2012

External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma ⬇️

artículo científico publicado el 15 de mayo de 2013

Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

artículo científico publicado en 2009

Finding Optimism in Clinical Trials: A Numbers Perspective

scientific article published on 01 September 2020

Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer

artículo científico publicado en 2006

Gemcitabine for advanced endometrial cancer: a retrospective study of the Memorial sloan-Kettering Cancer Center experience

artículo científico publicado en 2012

Geriatric Assessment as a Predictor of Delirium and Other Outcomes in Elderly Patients With Cancer

artículo científico publicado en 2014

Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer

artículo científico publicado en 2023

Germline variants in non-BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival.

artículo científico publicado en 2023

Hematologic changes after splenectomy for ovarian cancer debulking surgery, and association with infection and venous thromboembolism

artículo científico publicado en 2020

High Dose Chemoradiotherapy and ASCT Can Overcome the Prognostic Importance of Bcl-2, Bim, and p53 in Relapsed/Refractory Hodgkin’s Lymphoma. ⬇️

scholarly article

How to build and interpret a nomogram for cancer prognosis

scientific article published on March 2008

Identifying Clinical Improvement in Consolidation Single-Arm Phase 2 Trials in Patients With Ovarian Cancer in Second or Greater Clinical Remission ⬇️

artículo científico publicado el 1 de enero de 2012

Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.

artículo científico publicado en 2012

Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer

artículo científico publicado en 2011

Incorporating lower grade toxicity information into dose finding designs ⬇️

artículo científico publicado el 1 de agosto de 2011

Integrating the escalation and dose expansion studies into a unified Phase I clinical trial

artículo científico publicado en 2016

International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers

artículo científico publicado en 2018

Interplay of priors and skeletons in two‐stage continual reassessment method ⬇️

artículo científico publicado el 15 de agosto de 2012

Intraperitoneal chemotherapy after interval debulking surgery for advanced-stage ovarian cancer: Feasibility and outcomes at a comprehensive cancer center

artículo científico publicado en 2016

Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study

artículo científico publicado en 2023

Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?

artículo científico publicado en 2008

Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study

artículo científico publicado en 2023

Leave it in the past: Primary treatment modality for high-grade epithelial ovarian cancer does not affect secondary cytoreduction outcomes (173)

artículo científico publicado en 2023

Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy

artículo científico publicado en 2007

Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer

artículo científico publicado en 2008

Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival

scientific article published on 01 October 2006

MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

artículo científico publicado en 2022

Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation

artículo científico publicado en 2022

Measuring Toxicity in Phase I Clinical Trials--Letter

artículo científico publicado en 2016

Measuring differential treatment benefit across marker specific subgroups: The choice of outcome scale

artículo científico publicado en 2017

Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes

Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes (1242)

artículo científico publicado en 2023

Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial

artículo científico publicado en 2023

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center

artículo científico publicado en 2016

Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials

artículo científico publicado en 2014

Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.

artículo científico publicado en 2010

Ovarian clear cell carcinoma, outcomes by stage: the MSK experience

artículo científico publicado en 2015

Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors.

artículo científico publicado en 2015

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

artículo científico publicado en 2024

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study

artículo científico publicado en 2006

Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy

artículo científico publicado en 2019

Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors

artículo científico publicado en 2010

Perioperative epidural use and survival outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer

scientific article published on 02 September 2018

Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway

artículo científico publicado en 2019

Phase I Designs that Allow for Uncertainty in the Attribution of Adverse Events

artículo científico publicado en 2016

Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.

artículo científico publicado en 2006

Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma

artículo científico publicado en 2011

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer

scientific article published on 01 October 2020

Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

artículo científico publicado en 2013

Phase II study of intraperitoneal paclitaxel plus cisplatin and intravenous paclitaxel plus bevacizumab as adjuvant treatment of optimal stage II/III epithelial ovarian cancer

artículo científico publicado en 2011

Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function

scientific article published on 01 February 2007

Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma

artículo científico publicado en 2006

Picking the Right Patient for Human Epidermal Growth Factor Receptor 3-Targeted Therapy in Platinum-Resistant Ovarian Cancer

artículo científico publicado en 2016

Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer

artículo científico publicado en 2007

Positron lymphography via intracervical 18F-FDG injection for pre-surgical lymphatic mapping in cervical and endometrial malignancies

scientific article published on 10 January 2020

Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

artículo científico publicado en 2020

Predicting the histology of renal masses using preoperative Doppler ultrasonography

scientific article published on 01 January 2007

Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials

artículo científico publicado en 2015

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer

article

Prognostic and Predictive Values and Statistical Interactions in the Era of Targeted Treatment

artículo científico publicado en 2015

Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy

artículo científico publicado en 2013

Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer.

artículo científico publicado en 2015

Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial

artículo científico publicado en 2021

Prospective Comparative Study of Laparoscopic Narrow Band Imaging (NBI) Versus Standard Imaging in Gynecologic Oncology

artículo científico publicado en 2018

Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract

artículo científico publicado en 2007

Quantifying Treatment Benefit in Molecular Subgroups to Assess a Predictive Biomarker

artículo científico publicado en 2016

Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment

artículo científico publicado en 2013

Renal cell carcinoma in young and old patients--is there a difference?

artículo científico publicado en 2008

Reply to M. Voskoboynik et al

artículo científico publicado en 2014

Reply to M.P. Decatris et al

artículo científico publicado en 2016

Report of the 14th International Conference on Malignant Lymphoma (ICML) closed workshop on future design of clinical trials in lymphomas.

artículo científico publicado en 2018

Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma

artículo científico publicado en 2010

Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.

artículo científico publicado en 2008

Scientific Review of Phase I Protocols With Novel Dose-Escalation Designs: How Much Information Is Needed?

scientific article published on 04 May 2015

Sequential adjuvant chemotherapy after surgical resection of high-risk urothelial carcinoma

artículo científico publicado en 2009

Sequential monitoring of Phase I dose expansion cohorts.

artículo científico publicado en 2016

Specifying the True- and False-Positive Rates in Basket Trials

artículo científico publicado en 2017

Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature

artículo científico publicado en 2007

Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems

artículo científico publicado en 2009

Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer

artículo científico publicado en 2019

Surgical ovarian suppression for adjuvant treatment in hormone receptor positive breast cancer in premenopausal patients

scientific article published on 03 December 2020

Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery

artículo científico publicado en 2017

Surveillance patterns of cervical cancer patients treated with conization alone

scientific article published on 03 June 2020

Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping

artículo científico publicado en 2017

Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping

artículo científico publicado en 2015

Survival outcomes of acute normovolemic hemodilution in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study

artículo científico publicado en 2020

TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations

artículo científico publicado en 2019

The Impact of Non–Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials ⬇️

artículo científico publicado el 23 de julio de 2012

The MEMORY Study: MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes

scientific article published in 2022

The Utility of Consolidative Upfront High Dose Chemoradiotherapy and ASCT in Patients with Mantle Cell Lymphoma (MCL). ⬇️

artículo científico publicado en 2005

The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum

artículo científico publicado en 2010

The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer

scientific article published on 13 November 2007

The impact of near-infrared angiography and proctoscopy after rectosigmoid resection and anastomosis performed during surgeries for gynecologic malignancies

artículo científico publicado en 2020

The impact of tumor fragmentation in patients with stage I uterine leiomyosarcoma on patterns of recurrence and oncologic outcome

artículo científico publicado en 2020

The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center

artículo científico publicado en 2006

The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment

artículo científico publicado en 2009

The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?

artículo científico publicado en 2011

The role of systemic chemotherapy in the management of granulosa cell tumors

artículo científico publicado en 2014

Time to publication of oncology trials and why some trials are never published.

artículo científico publicado en 2017

Topotecan in patients with BRCA-associated and sporadic platinum-resistant ovarian, fallopian tube, and primary peritoneal cancers

artículo científico publicado en 2011

Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities

artículo científico publicado en 2015

Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009.

artículo científico publicado en 2013

Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors

artículo científico publicado en 2009

Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation

artículo científico publicado en 2013

Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy

artículo científico publicado en 2008

Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program

Variance prior specification for a basket trial design using Bayesian hierarchical modeling

scientific article published on 07 December 2018

Video-assisted thoracic surgery in the primary management of advanced ovarian carcinoma with moderate to large pleural effusions: A Memorial Sloan Kettering Cancer Center Team Ovary Study

scientific article published on 10 August 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda